Association between Inhaled Corticosteroid Use and SARS-CoV-2 Infection : A Nationwide Population-Based Study in South Korea

BACKGROUND: Although it is known that inhaled corticosteroid (ICS) use may increase the risk of respiratory infection, its influence on the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains unknown. Thus, the aim of this study was to investigate the association between ICS use and the positivity of SARS-CoV-2 infection among patients with chronic respiratory diseases.

METHODS: Nationwide data of 44,968 individuals with chronic respiratory diseases tested for SARS-CoV-2 until May 15, 2021 were obtained from the Ministry of Health and Welfare and Health Insurance Review and Assessment Service in Korea. The positivity of SARS-CoV-2 infection was retrospectively analysed according to the prescription, type, and dose of ICS taken one year before SARS-CoV-2 test.

RESULTS: Among 44,968 individuals tested, 931 (2.1%) were positive for SARS-CoV-2. A total of 7,019 patients (15.6%) were prescribed ICS one year prior to being tested for SARS-CoV-2. Low, medium, and high doses of ICS were prescribed in 7.5%, 1.6%, and 6.5% of total cases, respectively. Among types of ICS, budesonide, fluticasone, beclomethasone, and ciclesonide were prescribed in 3.7%, 8.9%, 2.3%, and 0.6% of total cases, respectively. A multivariate analysis showed no significant increase in infection with ICS use (odds ratio, 0.84; 95% confidence interval, 0.66-1.03). Moreover, there were no associations between the positivity of infection and the dose or type of ICS prescribed.

CONCLUSION: Prior ICS use did not increase the positivity for SARS-CoV-2 infection. Moreover, different doses or types of ICS did not affect this positivity.

Media Type:

Electronic Article

Year of Publication:

2022

Contained In:

Tuberculosis and respiratory diseases - Vol. 85, No. 1 (2022), p. 80-88

Language:

English

Contributors:

Lee, Sang Chul
Son, Kang Ju
Han, Chang Hoon
Jung, Ji Ye
Park, Seon Cheol

Links:

Volltext

Keywords:

Chronic Respiratory Diseases
Inhaled Corticosteroid
Journal Article
Risk
Severe Acute Respiratory Syndrome Coronavirus 2

Notes:

Date Revised 25.01.2022

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.4046/trd.2021.0102

PMID:

34844402

PPN (Catalogue-ID):

NLM334967090